Mean platelet volume/platelet count ratio and risk of progression in glioblastoma
J Wach, S Apallas, M Schneider, J Weller… - Frontiers in …, 2021 - frontiersin.org
Objective The mean platelet volume/platelet count (MPV/PC) ratio is an emerging biomarker
in selected types of cancer. The objective of this study is to analyze the association of …
in selected types of cancer. The objective of this study is to analyze the association of …
Pre‑operative mean platelet volume is associated with overall survival in patients with IDH‑wildtype glioblastoma undergoing maximal safe resection
S Snider, P De Domenico, F Roncelli… - Oncology …, 2024 - spandidos-publications.com
Glioblastoma (GBM) is the most common, fast-growing, and aggressive malignant primary
CNS tumor, with a survival time of~ 15 months despite the use of surgery and adjuvant …
CNS tumor, with a survival time of~ 15 months despite the use of surgery and adjuvant …